The Worldwide Virtual Clinical Trials Industry is Expected to Reach $5 Billion by 2027 - Decentralization of Clinical Trials Drives Growth - ResearchAndMarkets.com
19 Dec 2022
Clinical Study
DUBLIN--(BUSINESS WIRE)--The "Virtual Clinical Trials Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
'Virtual Clinical Trials Market - Global Outlook & Forecast 2022-2027'
The virtual clinical trials market is one of the innovative approaches for traditional clinical trials, through remote monitoring and more patient-centric approaches.
These virtual clinical trials adoption was high during the COVID-19 pandemic period and the usage of decentralized clinical trials components application rate. Most clinical trial conductors started to move towards the decentralized or hybrid clinical trial model.
Virtual clinical trials are also known as de-centralized clinical trials. Although the vendors adopted virtual clinical trials for many years, however, it was very slow adoption before the pandemic.
The virtual clinical trials market includes the application of digital tools and technological processes that take trials from healthcare settings to patients' homes or places of work.
The reduction in site visits, associated time, and economic cost cuttings eliminate the burden placed on patients and solve the challenges for trial participation. The virtual clinical trials market brought significant advantages and reduced major challenges like patient retention, recruitment, and more. These are the factors that fuel market growth.
Key Questions Answered:
1. What is the size of the global virtual clinical trials market?
2. What is the global virtual clinical trials market growth?
3. What are the trends in the global virtual clinical trials market?
4. Who are the key players in the global virtual clinical trials market?
5. Which region will dominate the global virtual clinical trials market share?
Market Dynamics
Opportunities & Trends
Adoption of "Bring-Your-Own-Device" Strategy
Clinical Trials Powered With Better Data Through New Connected Devices
Adoption of Synthetic Clinical Trials
Growth Enablers
Spike in Virtual Clinical Trial Adoption Due to Covid-19
Decentralization of Clinical Trials
Regulatory Changes in Favor of Virtual Clinical Trials
Growth Restraints
Challenges Associated With Virtual Clinical Trials
Complexity in Decentralized Clinical Trials
Increasing Alternatives for Virtual Clinical Trials
Market Segmentation
by Study Type
Interventional
Others
by Phases
Late Stage
Early Stage
by Therapeutic Area
Oncology
Rare & Genetic Diseases
CNS
Immunology
Other
Segmentation by Company Size
Small & Mid-Sized
Large Sized
by Geography
North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
APAC
Japan
China
India
South Korea
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Turkey
Saudi Arabia
South Africa
Key Company Profiles
Medable
Science 37
THREAD
Key Companies To Watch
Accenture
Castor
Clinical ink
Clario
Delve Health
eClinicalHealth
IQVIA
Labcorp Drug Development
Signant Health
Other Prominent Vendors
Advarra
Curavit Clinical Research
LEO Innovation Lab
Oracle
Paraxel International Corporation
For more information about this report visit https://www.researchandmarkets.com/r/ifmh4m
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.